GTHX earnings call for the period ending September 30, 2019.
News & Analysis: G1 Therapeutics, Inc.
Some investors think the market's been too hard on these drugmakers.
After soaring almost 70% year to date, G1 shares were under pressure following new data on two drug candidates.
Unfortunately, there were more of the latter.
Tough going kept these stocks from joining the rally.
GTHX earnings call for the period ending June 30, 2019.
These stocks were huge winners last week. But can their momentum continue?
Favorable comments from analysts helped some of these power players stand out on a strong day for the market.
GTHX earnings call for the period ending March 31, 2019.
The clinical-stage biopharmaceutical company is on track to file for FDA approval of its first drug, trilaciclib.